nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—Rash—Mometasone—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Carbidopa—Asthenia—Captopril—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Carbidopa—Dermatitis—Mometasone—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Carbidopa—Decreased appetite—Leflunomide—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Carbidopa—Confusional state—Lisinopril—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Carbidopa—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Carbidopa—Headache—Mometasone—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Carbidopa—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Carbidopa—Insomnia—Mycophenolic acid—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Carbidopa—Fatigue—Leflunomide—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Carbidopa—Oedema—Lisinopril—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Carbidopa—Pruritus—Captopril—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Carbidopa—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Carbidopa—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Carbidopa—Pain—Leflunomide—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Carbidopa—Constipation—Leflunomide—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Carbidopa—Infection—Lisinopril—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Carbidopa—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Carbidopa—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Carbidopa—Somnolence—Mycophenolic acid—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Carbidopa—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Carbidopa—Shock—Lisinopril—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Carbidopa—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Carbidopa—Thrombocytopenia—Lisinopril—systemic scleroderma	0.001	0.001	CcSEcCtD
Carbidopa—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.001	0.001	CcSEcCtD
Carbidopa—Abdominal pain—Azathioprine—systemic scleroderma	0.000998	0.000998	CcSEcCtD
Carbidopa—Body temperature increased—Azathioprine—systemic scleroderma	0.000998	0.000998	CcSEcCtD
Carbidopa—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000992	0.000992	CcSEcCtD
Carbidopa—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000991	0.000991	CcSEcCtD
Carbidopa—Diarrhoea—Captopril—systemic scleroderma	0.00099	0.00099	CcSEcCtD
Carbidopa—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000989	0.000989	CcSEcCtD
Carbidopa—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000986	0.000986	CcSEcCtD
Carbidopa—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000985	0.000985	CcSEcCtD
Carbidopa—Feeling abnormal—Leflunomide—systemic scleroderma	0.000983	0.000983	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000982	0.000982	CcSEcCtD
Carbidopa—Fatigue—Mycophenolic acid—systemic scleroderma	0.000981	0.000981	CcSEcCtD
Carbidopa—Nausea—Mometasone—systemic scleroderma	0.000978	0.000978	CcSEcCtD
Carbidopa—Anorexia—Lisinopril—systemic scleroderma	0.000977	0.000977	CcSEcCtD
Carbidopa—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000975	0.000975	CcSEcCtD
Carbidopa—Weight increased—Prednisone—systemic scleroderma	0.000974	0.000974	CcSEcCtD
Carbidopa—Ataxia—Methotrexate—systemic scleroderma	0.000973	0.000973	CcSEcCtD
Carbidopa—Constipation—Mycophenolic acid—systemic scleroderma	0.000973	0.000973	CcSEcCtD
Carbidopa—Pain—Mycophenolic acid—systemic scleroderma	0.000973	0.000973	CcSEcCtD
Carbidopa—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000972	0.000972	CcSEcCtD
Carbidopa—Weight decreased—Prednisone—systemic scleroderma	0.000968	0.000968	CcSEcCtD
Carbidopa—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000967	0.000967	CcSEcCtD
Carbidopa—Cough—Mycophenolate mofetil—systemic scleroderma	0.00096	0.00096	CcSEcCtD
Carbidopa—Hypotension—Lisinopril—systemic scleroderma	0.000957	0.000957	CcSEcCtD
Carbidopa—Dizziness—Captopril—systemic scleroderma	0.000957	0.000957	CcSEcCtD
Carbidopa—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000953	0.000953	CcSEcCtD
Carbidopa—Depression—Prednisone—systemic scleroderma	0.000951	0.000951	CcSEcCtD
Carbidopa—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00095	0.00095	CcSEcCtD
Carbidopa—Urticaria—Leflunomide—systemic scleroderma	0.000947	0.000947	CcSEcCtD
Carbidopa—Abdominal pain—Leflunomide—systemic scleroderma	0.000943	0.000943	CcSEcCtD
Carbidopa—Body temperature increased—Leflunomide—systemic scleroderma	0.000943	0.000943	CcSEcCtD
Carbidopa—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000941	0.000941	CcSEcCtD
Carbidopa—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000937	0.000937	CcSEcCtD
Carbidopa—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000936	0.000936	CcSEcCtD
Carbidopa—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000935	0.000935	CcSEcCtD
Carbidopa—Myocardial infarction—Prednisone—systemic scleroderma	0.000935	0.000935	CcSEcCtD
Carbidopa—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000933	0.000933	CcSEcCtD
Carbidopa—Hypersensitivity—Azathioprine—systemic scleroderma	0.00093	0.00093	CcSEcCtD
Carbidopa—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00093	0.00093	CcSEcCtD
Carbidopa—Insomnia—Lisinopril—systemic scleroderma	0.000927	0.000927	CcSEcCtD
Carbidopa—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000925	0.000925	CcSEcCtD
Carbidopa—Paraesthesia—Lisinopril—systemic scleroderma	0.00092	0.00092	CcSEcCtD
Carbidopa—Vomiting—Captopril—systemic scleroderma	0.00092	0.00092	CcSEcCtD
Carbidopa—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000916	0.000916	CcSEcCtD
Carbidopa—Dyspnoea—Lisinopril—systemic scleroderma	0.000913	0.000913	CcSEcCtD
Carbidopa—Rash—Captopril—systemic scleroderma	0.000912	0.000912	CcSEcCtD
Carbidopa—Dermatitis—Captopril—systemic scleroderma	0.000911	0.000911	CcSEcCtD
Carbidopa—Somnolence—Lisinopril—systemic scleroderma	0.000911	0.000911	CcSEcCtD
Carbidopa—Headache—Captopril—systemic scleroderma	0.000906	0.000906	CcSEcCtD
Carbidopa—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000905	0.000905	CcSEcCtD
Carbidopa—Dyspepsia—Lisinopril—systemic scleroderma	0.000902	0.000902	CcSEcCtD
Carbidopa—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000899	0.000899	CcSEcCtD
Carbidopa—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000899	0.000899	CcSEcCtD
Carbidopa—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000898	0.000898	CcSEcCtD
Carbidopa—Infection—Mycophenolate mofetil—systemic scleroderma	0.000892	0.000892	CcSEcCtD
Carbidopa—Decreased appetite—Lisinopril—systemic scleroderma	0.000891	0.000891	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000885	0.000885	CcSEcCtD
Carbidopa—Fatigue—Lisinopril—systemic scleroderma	0.000883	0.000883	CcSEcCtD
Carbidopa—Shock—Mycophenolate mofetil—systemic scleroderma	0.000883	0.000883	CcSEcCtD
Carbidopa—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000879	0.000879	CcSEcCtD
Carbidopa—Hypersensitivity—Leflunomide—systemic scleroderma	0.000879	0.000879	CcSEcCtD
Carbidopa—Constipation—Lisinopril—systemic scleroderma	0.000876	0.000876	CcSEcCtD
Carbidopa—Pain—Lisinopril—systemic scleroderma	0.000876	0.000876	CcSEcCtD
Carbidopa—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000868	0.000868	CcSEcCtD
Carbidopa—Diarrhoea—Azathioprine—systemic scleroderma	0.000864	0.000864	CcSEcCtD
Carbidopa—Haemoglobin—Prednisone—systemic scleroderma	0.000861	0.000861	CcSEcCtD
Carbidopa—Nausea—Captopril—systemic scleroderma	0.000859	0.000859	CcSEcCtD
Carbidopa—Haemorrhage—Prednisone—systemic scleroderma	0.000857	0.000857	CcSEcCtD
Carbidopa—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000856	0.000856	CcSEcCtD
Carbidopa—Asthenia—Leflunomide—systemic scleroderma	0.000856	0.000856	CcSEcCtD
Carbidopa—Hallucination—Prednisone—systemic scleroderma	0.000852	0.000852	CcSEcCtD
Carbidopa—Feeling abnormal—Lisinopril—systemic scleroderma	0.000844	0.000844	CcSEcCtD
Carbidopa—Pruritus—Leflunomide—systemic scleroderma	0.000844	0.000844	CcSEcCtD
Carbidopa—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000839	0.000839	CcSEcCtD
Carbidopa—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000838	0.000838	CcSEcCtD
Carbidopa—Dizziness—Azathioprine—systemic scleroderma	0.000835	0.000835	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000831	0.000831	CcSEcCtD
Carbidopa—Asthenia—Mycophenolic acid—systemic scleroderma	0.000816	0.000816	CcSEcCtD
Carbidopa—Diarrhoea—Leflunomide—systemic scleroderma	0.000816	0.000816	CcSEcCtD
Carbidopa—Urticaria—Lisinopril—systemic scleroderma	0.000814	0.000814	CcSEcCtD
Carbidopa—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000812	0.000812	CcSEcCtD
Carbidopa—Body temperature increased—Lisinopril—systemic scleroderma	0.00081	0.00081	CcSEcCtD
Carbidopa—Abdominal pain—Lisinopril—systemic scleroderma	0.00081	0.00081	CcSEcCtD
Carbidopa—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000806	0.000806	CcSEcCtD
Carbidopa—Pruritus—Mycophenolic acid—systemic scleroderma	0.000805	0.000805	CcSEcCtD
Carbidopa—Vomiting—Azathioprine—systemic scleroderma	0.000803	0.000803	CcSEcCtD
Carbidopa—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.0008	0.0008	CcSEcCtD
Carbidopa—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000798	0.000798	CcSEcCtD
Carbidopa—Rash—Azathioprine—systemic scleroderma	0.000796	0.000796	CcSEcCtD
Carbidopa—Dermatitis—Azathioprine—systemic scleroderma	0.000795	0.000795	CcSEcCtD
Carbidopa—Depression—Methotrexate—systemic scleroderma	0.000795	0.000795	CcSEcCtD
Carbidopa—Flushing—Prednisone—systemic scleroderma	0.000795	0.000795	CcSEcCtD
Carbidopa—Headache—Azathioprine—systemic scleroderma	0.000791	0.000791	CcSEcCtD
Carbidopa—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00079	0.00079	CcSEcCtD
Carbidopa—Dizziness—Leflunomide—systemic scleroderma	0.000789	0.000789	CcSEcCtD
Carbidopa—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00078	0.00078	CcSEcCtD
Carbidopa—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000778	0.000778	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000775	0.000775	CcSEcCtD
Carbidopa—Pain—Mycophenolate mofetil—systemic scleroderma	0.000768	0.000768	CcSEcCtD
Carbidopa—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000768	0.000768	CcSEcCtD
Carbidopa—Vomiting—Leflunomide—systemic scleroderma	0.000758	0.000758	CcSEcCtD
Carbidopa—Alopecia—Prednisone—systemic scleroderma	0.000757	0.000757	CcSEcCtD
Carbidopa—Hypersensitivity—Lisinopril—systemic scleroderma	0.000755	0.000755	CcSEcCtD
Carbidopa—Dizziness—Mycophenolic acid—systemic scleroderma	0.000752	0.000752	CcSEcCtD
Carbidopa—Rash—Leflunomide—systemic scleroderma	0.000752	0.000752	CcSEcCtD
Carbidopa—Dermatitis—Leflunomide—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Carbidopa—Mental disorder—Prednisone—systemic scleroderma	0.00075	0.00075	CcSEcCtD
Carbidopa—Nausea—Azathioprine—systemic scleroderma	0.00075	0.00075	CcSEcCtD
Carbidopa—Headache—Leflunomide—systemic scleroderma	0.000747	0.000747	CcSEcCtD
Carbidopa—Agranulocytosis—Methotrexate—systemic scleroderma	0.000744	0.000744	CcSEcCtD
Carbidopa—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00074	0.00074	CcSEcCtD
Carbidopa—Asthenia—Lisinopril—systemic scleroderma	0.000735	0.000735	CcSEcCtD
Carbidopa—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000734	0.000734	CcSEcCtD
Carbidopa—Pruritus—Lisinopril—systemic scleroderma	0.000725	0.000725	CcSEcCtD
Carbidopa—Vomiting—Mycophenolic acid—systemic scleroderma	0.000723	0.000723	CcSEcCtD
Carbidopa—Haemoglobin—Methotrexate—systemic scleroderma	0.000719	0.000719	CcSEcCtD
Carbidopa—Rash—Mycophenolic acid—systemic scleroderma	0.000717	0.000717	CcSEcCtD
Carbidopa—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000717	0.000717	CcSEcCtD
Carbidopa—Haemorrhage—Methotrexate—systemic scleroderma	0.000716	0.000716	CcSEcCtD
Carbidopa—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000713	0.000713	CcSEcCtD
Carbidopa—Headache—Mycophenolic acid—systemic scleroderma	0.000713	0.000713	CcSEcCtD
Carbidopa—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00071	0.00071	CcSEcCtD
Carbidopa—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00071	0.00071	CcSEcCtD
Carbidopa—Nausea—Leflunomide—systemic scleroderma	0.000708	0.000708	CcSEcCtD
Carbidopa—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000707	0.000707	CcSEcCtD
Carbidopa—Vision blurred—Prednisone—systemic scleroderma	0.000703	0.000703	CcSEcCtD
Carbidopa—Urethral disorder—Methotrexate—systemic scleroderma	0.000702	0.000702	CcSEcCtD
Carbidopa—Diarrhoea—Lisinopril—systemic scleroderma	0.000701	0.000701	CcSEcCtD
Carbidopa—Ill-defined disorder—Prednisone—systemic scleroderma	0.000692	0.000692	CcSEcCtD
Carbidopa—Anaemia—Prednisone—systemic scleroderma	0.000689	0.000689	CcSEcCtD
Carbidopa—Agitation—Prednisone—systemic scleroderma	0.000685	0.000685	CcSEcCtD
Carbidopa—Angioedema—Prednisone—systemic scleroderma	0.000681	0.000681	CcSEcCtD
Carbidopa—Dizziness—Lisinopril—systemic scleroderma	0.000678	0.000678	CcSEcCtD
Carbidopa—Nausea—Mycophenolic acid—systemic scleroderma	0.000676	0.000676	CcSEcCtD
Carbidopa—Malaise—Prednisone—systemic scleroderma	0.000672	0.000672	CcSEcCtD
Carbidopa—Syncope—Prednisone—systemic scleroderma	0.000669	0.000669	CcSEcCtD
Carbidopa—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000661	0.000661	CcSEcCtD
Carbidopa—Loss of consciousness—Prednisone—systemic scleroderma	0.000655	0.000655	CcSEcCtD
Carbidopa—Vomiting—Lisinopril—systemic scleroderma	0.000651	0.000651	CcSEcCtD
Carbidopa—Rash—Lisinopril—systemic scleroderma	0.000646	0.000646	CcSEcCtD
Carbidopa—Convulsion—Prednisone—systemic scleroderma	0.000646	0.000646	CcSEcCtD
Carbidopa—Dermatitis—Lisinopril—systemic scleroderma	0.000645	0.000645	CcSEcCtD
Carbidopa—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000644	0.000644	CcSEcCtD
Carbidopa—Hypertension—Prednisone—systemic scleroderma	0.000644	0.000644	CcSEcCtD
Carbidopa—Headache—Lisinopril—systemic scleroderma	0.000642	0.000642	CcSEcCtD
Carbidopa—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000635	0.000635	CcSEcCtD
Carbidopa—Anxiety—Prednisone—systemic scleroderma	0.000633	0.000633	CcSEcCtD
Carbidopa—Alopecia—Methotrexate—systemic scleroderma	0.000633	0.000633	CcSEcCtD
Carbidopa—Discomfort—Prednisone—systemic scleroderma	0.000627	0.000627	CcSEcCtD
Carbidopa—Mental disorder—Methotrexate—systemic scleroderma	0.000627	0.000627	CcSEcCtD
Carbidopa—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000614	0.000614	CcSEcCtD
Carbidopa—Dysgeusia—Methotrexate—systemic scleroderma	0.00061	0.00061	CcSEcCtD
Carbidopa—Nausea—Lisinopril—systemic scleroderma	0.000609	0.000609	CcSEcCtD
Carbidopa—Oedema—Prednisone—systemic scleroderma	0.000609	0.000609	CcSEcCtD
Carbidopa—Infection—Prednisone—systemic scleroderma	0.000605	0.000605	CcSEcCtD
Carbidopa—Back pain—Methotrexate—systemic scleroderma	0.000603	0.000603	CcSEcCtD
Carbidopa—Shock—Prednisone—systemic scleroderma	0.000599	0.000599	CcSEcCtD
Carbidopa—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000594	0.000594	CcSEcCtD
Carbidopa—Hyperhidrosis—Prednisone—systemic scleroderma	0.000588	0.000588	CcSEcCtD
Carbidopa—Vision blurred—Methotrexate—systemic scleroderma	0.000587	0.000587	CcSEcCtD
Carbidopa—Anorexia—Prednisone—systemic scleroderma	0.00058	0.00058	CcSEcCtD
Carbidopa—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000578	0.000578	CcSEcCtD
Carbidopa—Anaemia—Methotrexate—systemic scleroderma	0.000576	0.000576	CcSEcCtD
Carbidopa—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000571	0.000571	CcSEcCtD
Carbidopa—Rash—Mycophenolate mofetil—systemic scleroderma	0.000566	0.000566	CcSEcCtD
Carbidopa—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000566	0.000566	CcSEcCtD
Carbidopa—Headache—Mycophenolate mofetil—systemic scleroderma	0.000562	0.000562	CcSEcCtD
Carbidopa—Malaise—Methotrexate—systemic scleroderma	0.000562	0.000562	CcSEcCtD
Carbidopa—Leukopenia—Methotrexate—systemic scleroderma	0.000558	0.000558	CcSEcCtD
Carbidopa—Insomnia—Prednisone—systemic scleroderma	0.00055	0.00055	CcSEcCtD
Carbidopa—Paraesthesia—Prednisone—systemic scleroderma	0.000546	0.000546	CcSEcCtD
Carbidopa—Cough—Methotrexate—systemic scleroderma	0.000544	0.000544	CcSEcCtD
Carbidopa—Convulsion—Methotrexate—systemic scleroderma	0.00054	0.00054	CcSEcCtD
Carbidopa—Dyspepsia—Prednisone—systemic scleroderma	0.000536	0.000536	CcSEcCtD
Carbidopa—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000533	0.000533	CcSEcCtD
Carbidopa—Chest pain—Methotrexate—systemic scleroderma	0.000531	0.000531	CcSEcCtD
Carbidopa—Decreased appetite—Prednisone—systemic scleroderma	0.000529	0.000529	CcSEcCtD
Carbidopa—Fatigue—Prednisone—systemic scleroderma	0.000525	0.000525	CcSEcCtD
Carbidopa—Discomfort—Methotrexate—systemic scleroderma	0.000524	0.000524	CcSEcCtD
Carbidopa—Constipation—Prednisone—systemic scleroderma	0.00052	0.00052	CcSEcCtD
Carbidopa—Confusional state—Methotrexate—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Carbidopa—Infection—Methotrexate—systemic scleroderma	0.000505	0.000505	CcSEcCtD
Carbidopa—Feeling abnormal—Prednisone—systemic scleroderma	0.000501	0.000501	CcSEcCtD
Carbidopa—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000498	0.000498	CcSEcCtD
Carbidopa—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000498	0.000498	CcSEcCtD
Carbidopa—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000492	0.000492	CcSEcCtD
Carbidopa—Anorexia—Methotrexate—systemic scleroderma	0.000485	0.000485	CcSEcCtD
Carbidopa—Urticaria—Prednisone—systemic scleroderma	0.000483	0.000483	CcSEcCtD
Carbidopa—Abdominal pain—Prednisone—systemic scleroderma	0.000481	0.000481	CcSEcCtD
Carbidopa—Body temperature increased—Prednisone—systemic scleroderma	0.000481	0.000481	CcSEcCtD
Carbidopa—Hypotension—Methotrexate—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Carbidopa—Insomnia—Methotrexate—systemic scleroderma	0.00046	0.00046	CcSEcCtD
Carbidopa—Paraesthesia—Methotrexate—systemic scleroderma	0.000457	0.000457	CcSEcCtD
Carbidopa—Dyspnoea—Methotrexate—systemic scleroderma	0.000453	0.000453	CcSEcCtD
Carbidopa—Somnolence—Methotrexate—systemic scleroderma	0.000452	0.000452	CcSEcCtD
Carbidopa—Hypersensitivity—Prednisone—systemic scleroderma	0.000448	0.000448	CcSEcCtD
Carbidopa—Dyspepsia—Methotrexate—systemic scleroderma	0.000448	0.000448	CcSEcCtD
Carbidopa—Decreased appetite—Methotrexate—systemic scleroderma	0.000442	0.000442	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000439	0.000439	CcSEcCtD
Carbidopa—Fatigue—Methotrexate—systemic scleroderma	0.000438	0.000438	CcSEcCtD
Carbidopa—Asthenia—Prednisone—systemic scleroderma	0.000437	0.000437	CcSEcCtD
Carbidopa—Pain—Methotrexate—systemic scleroderma	0.000435	0.000435	CcSEcCtD
Carbidopa—Pruritus—Prednisone—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Carbidopa—Feeling abnormal—Methotrexate—systemic scleroderma	0.000419	0.000419	CcSEcCtD
Carbidopa—Diarrhoea—Prednisone—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Carbidopa—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Carbidopa—Urticaria—Methotrexate—systemic scleroderma	0.000404	0.000404	CcSEcCtD
Carbidopa—Dizziness—Prednisone—systemic scleroderma	0.000402	0.000402	CcSEcCtD
Carbidopa—Abdominal pain—Methotrexate—systemic scleroderma	0.000402	0.000402	CcSEcCtD
Carbidopa—Body temperature increased—Methotrexate—systemic scleroderma	0.000402	0.000402	CcSEcCtD
Carbidopa—Vomiting—Prednisone—systemic scleroderma	0.000387	0.000387	CcSEcCtD
Carbidopa—Rash—Prednisone—systemic scleroderma	0.000384	0.000384	CcSEcCtD
Carbidopa—Dermatitis—Prednisone—systemic scleroderma	0.000383	0.000383	CcSEcCtD
Carbidopa—Headache—Prednisone—systemic scleroderma	0.000381	0.000381	CcSEcCtD
Carbidopa—Hypersensitivity—Methotrexate—systemic scleroderma	0.000375	0.000375	CcSEcCtD
Carbidopa—Asthenia—Methotrexate—systemic scleroderma	0.000365	0.000365	CcSEcCtD
Carbidopa—Nausea—Prednisone—systemic scleroderma	0.000361	0.000361	CcSEcCtD
Carbidopa—Pruritus—Methotrexate—systemic scleroderma	0.00036	0.00036	CcSEcCtD
Carbidopa—Diarrhoea—Methotrexate—systemic scleroderma	0.000348	0.000348	CcSEcCtD
Carbidopa—Dizziness—Methotrexate—systemic scleroderma	0.000336	0.000336	CcSEcCtD
Carbidopa—Vomiting—Methotrexate—systemic scleroderma	0.000323	0.000323	CcSEcCtD
Carbidopa—Rash—Methotrexate—systemic scleroderma	0.000321	0.000321	CcSEcCtD
Carbidopa—Dermatitis—Methotrexate—systemic scleroderma	0.00032	0.00032	CcSEcCtD
Carbidopa—Headache—Methotrexate—systemic scleroderma	0.000319	0.000319	CcSEcCtD
Carbidopa—Nausea—Methotrexate—systemic scleroderma	0.000302	0.000302	CcSEcCtD
